<div class="lightbox-header">
    <h2 class="title">TOM HASWELL</h2>
    <p>Patient representative<p>
</div>
<div class="lightbox-body">
    <img alt="Profile photo of Tom Haswell" src="../../../public/cms/150/318/47/1138/3N1anN_web.jpg" width="140" height="140" />
    <p><span style="font-size: small;">Tom&rsquo;s background was in engineering and for many years he worked overseas until 1993 when he travelled to Saudi Arabia to start a new job. At the subsequent medical he was told he had lung cancer. He returned home to Glasgow, underwent further tests and was then told there was no treatment available which would have any effect on his illness and was given 3 to 9 months to live. He was invited to take part in an early phase clinical trial, underwent 6 months of chemotherapy which was then followed by 13 sessions of radiotherapy. The outcome being, registered disabled medically retired unable to work, alive and with an acceptable quality of life considering his prognosis.</span></p>
<p>&nbsp;</p>
<p><span style="font-size: small;">I</span><span style="font-size: small;">n 1997 Tom was given the opportunity to become involved in patient/consumer issues initially through his involvement with a lung cancer charity. He was a lay representative with the Clinical Standards Board for Scotland then public partner with Quality Improvement Scotland. In 2004 he was invited to join the National Cancer Research Institutes Strategic Planning Group looking at research into lung cancer following which he became a member of the National Cancer Research Institutes Consumer Liaison Group, Lung Cancer Clinical Studies Group, and Consumer Involvement Steering Group. He is also a member of the Dept. of Health Lung Cancer and Mesothelioma Adv isory Group, and a member of NICE Lung Cancer Guidelines Development Group, Commissioning Outcomes Framework and Quality Outcomes Framework. Recently he has been appointed to the National Cancer Intelligence Network Lung Site Specific Reference Group and the National Lung Cancer Audit Reference Group. Locally, Tom is a member of the West of Scotland Cancer Network Regional Cancer Advisory Group and Partnership Forum. He has involvements with other organisations such as CRUK, CCRC, etc., and is an executive member of CACTUS(Cancer Clinical Trials Unit for Scotland), West of Scotland Cancer Research Network Trials Executive Committee and In House Trials Advisory Board at The Beatson West of Scotland Cancer Centre. He attends events and conferences relative to his patient involvements, and has had considerable involvement with the media.</span></p>    </div>